close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

473.20 +0.08 (+0.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
Liquidia: Court victory the awakening of an industry giant?
Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying. 
Via MarketBeat
Topics Intellectual Property
News headline image
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today? ↗
Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a pat 
Via Benzinga
News headline image
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
From United Therapeutics Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 21, 2024 ↗
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
News headline image
Earnings Outlook For United Therapeutics ↗
 
Via Benzinga
News headline image
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate ↗
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ: 
Via Benzinga
Topics Intellectual Property
News headline image
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January ↗
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions. 
Via InvestorPlace
News headline image
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market ↗
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for. 
Via InvestorPlace
News headline image
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
From United Therapeutics Corporation
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
Via InvestorPlace
News headline image
Flying Car Stocks: What a Devastating Short Report Means for EHang ↗
Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch. 
Via InvestorPlace
News headline image
EH Stock Alert: Hindenburg Slams EHang in New Short Report ↗
EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm. 
Via InvestorPlace
News headline image
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 1, 2023 ↗
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
News headline image
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical ↗
 
Via Benzinga
News headline image
Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today? ↗
United Therapeutics Corporation (NASDAQ: UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ: MIRO) for $3.25 per share in cash (an aggregate of approximately $91 million). 
Via Benzinga
News headline image
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today? ↗
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! 
Via InvestorPlace
News headline image
United Therapeutics to Acquire Miromatrix Medical
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
United Therapeutics to Acquire Miromatrix Medical
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
From United Therapeutics Corporation
Via Business Wire
News headline image
Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023 ↗
Defensive stocks have always been the go-to investments for those looking to protect their long-term portfolio and weather downturns. 
Via InvestorPlace
News headline image
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
From United Therapeutics Corporation
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today